author-photo

Bart Burington

Genentech

13

Papers

75

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Estimating duration in partnership studies: issues, methods and examples

2010 Sexually Transmitted Infections
Show All
- Source
- Cite
- Save
Citations (15)
Statistical techniques to construct assays for identifying likely responders to a treatment under evaluation from cell line genomic data.

2010 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Estimating duration in partnership studies: issues, methods and examples

2010 Archives of Disease in Childhood
Show All
- Source
- Cite
- Save
Citations (0)
CD40 Pathway Activation Status Predicts Response to CD40 Targeted Therapy in Diffuse Large b-Cell Lymphoma.

2009 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Evaluation of a gene signature to predict single agent dacetuzumab (SGN-40) activity in patients with DLBCL

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract #LB-138: A gene signature predicts sensitivity to the partial CD40 agonist, dacetuzumab (SGN-40), in patients with diffuse large B-cell lymphoma

2009 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A Phase I Study of PRO131921, a Novel Anti-CD20 Monoclonal Antibody in Patients with Relapsed/Refractory CD20+ Indolent NHL: Correlation Between Clinical Responses and AUC Pharmacokinetics.

2009 Blood
Show All
- Source
- Cite
- Save
Citations (13)
CD40 pathway activation status and germinal B-cell identity are predictive of response to anti-CD40 (SGN-40) in preclinical NHL models

2008 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)